nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0659	0.463	CbGbCtD
Methylergometrine—CYP3A4—Progesterone—uterine cancer	0.0436	0.307	CbGbCtD
Methylergometrine—Cramps of lower extremities—Progesterone—uterine cancer	0.0219	0.0279	CcSEcCtD
Methylergometrine—Thrombophlebitis—Progesterone—uterine cancer	0.02	0.0255	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Medroxyprogesterone Acetate—uterine cancer	0.0198	0.0253	CcSEcCtD
Methylergometrine—CYP3A4—Etoposide—uterine cancer	0.0195	0.137	CbGbCtD
Methylergometrine—Nasal congestion—Progesterone—uterine cancer	0.019	0.0242	CcSEcCtD
Methylergometrine—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.0181	0.0231	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.016	0.0204	CcSEcCtD
Methylergometrine—Angina pectoris—Progesterone—uterine cancer	0.0146	0.0186	CcSEcCtD
Methylergometrine—Sweating increased—Progesterone—uterine cancer	0.0146	0.0186	CcSEcCtD
Methylergometrine—CYP3A4—Doxorubicin—uterine cancer	0.0133	0.0936	CbGbCtD
Methylergometrine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.0132	0.0168	CcSEcCtD
Methylergometrine—HTR1E—myometrium—uterine cancer	0.0125	0.169	CbGeAlD
Methylergometrine—Tinnitus—Progesterone—uterine cancer	0.0112	0.0142	CcSEcCtD
Methylergometrine—Cardiac disorder—Progesterone—uterine cancer	0.0111	0.0142	CcSEcCtD
Methylergometrine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.011	0.0141	CcSEcCtD
Methylergometrine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0129	CcSEcCtD
Methylergometrine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0128	CcSEcCtD
Methylergometrine—Muscle spasms—Progesterone—uterine cancer	0.01	0.0128	CcSEcCtD
Methylergometrine—Palpitations—Progesterone—uterine cancer	0.00921	0.0118	CcSEcCtD
Methylergometrine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00908	0.0116	CcSEcCtD
Methylergometrine—Convulsion—Progesterone—uterine cancer	0.00903	0.0115	CcSEcCtD
Methylergometrine—Hypertension—Progesterone—uterine cancer	0.009	0.0115	CcSEcCtD
Methylergometrine—Chest pain—Progesterone—uterine cancer	0.00887	0.0113	CcSEcCtD
Methylergometrine—Anaphylactic shock—Progesterone—uterine cancer	0.00851	0.0109	CcSEcCtD
Methylergometrine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00835	0.0106	CcSEcCtD
Methylergometrine—Nervous system disorder—Progesterone—uterine cancer	0.00834	0.0106	CcSEcCtD
Methylergometrine—Tachycardia—Progesterone—uterine cancer	0.0083	0.0106	CcSEcCtD
Methylergometrine—Hyperhidrosis—Progesterone—uterine cancer	0.00822	0.0105	CcSEcCtD
Methylergometrine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00818	0.0104	CcSEcCtD
Methylergometrine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00804	0.0103	CcSEcCtD
Methylergometrine—Hypotension—Progesterone—uterine cancer	0.00795	0.0101	CcSEcCtD
Methylergometrine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00771	0.00984	CcSEcCtD
Methylergometrine—Paraesthesia—Progesterone—uterine cancer	0.00764	0.00975	CcSEcCtD
Methylergometrine—Dyspnoea—Progesterone—uterine cancer	0.00758	0.00968	CcSEcCtD
Methylergometrine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00756	0.00965	CcSEcCtD
Methylergometrine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00752	0.0096	CcSEcCtD
Methylergometrine—Sweating increased—Etoposide—uterine cancer	0.00745	0.00951	CcSEcCtD
Methylergometrine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00745	0.00951	CcSEcCtD
Methylergometrine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0072	0.00919	CcSEcCtD
Methylergometrine—Atrioventricular block—Epirubicin—uterine cancer	0.00705	0.00899	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Progesterone—uterine cancer	0.00696	0.00888	CcSEcCtD
Methylergometrine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00692	0.00883	CcSEcCtD
Methylergometrine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00687	0.00877	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Epirubicin—uterine cancer	0.00684	0.00872	CcSEcCtD
Methylergometrine—Abdominal pain—Progesterone—uterine cancer	0.00672	0.00858	CcSEcCtD
Methylergometrine—HTR1E—female gonad—uterine cancer	0.00665	0.0899	CbGeAlD
Methylergometrine—Atrioventricular block—Doxorubicin—uterine cancer	0.00652	0.00832	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00633	0.00807	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0063	0.00804	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Epirubicin—uterine cancer	0.00628	0.00801	CcSEcCtD
Methylergometrine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00609	0.00777	CcSEcCtD
Methylergometrine—HTR2A—artery—uterine cancer	0.0059	0.0798	CbGeAlD
Methylergometrine—Diarrhoea—Progesterone—uterine cancer	0.00582	0.00743	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Doxorubicin—uterine cancer	0.00581	0.00742	CcSEcCtD
Methylergometrine—Thrombophlebitis—Epirubicin—uterine cancer	0.00573	0.00732	CcSEcCtD
Methylergometrine—Cardiac disorder—Etoposide—uterine cancer	0.00568	0.00725	CcSEcCtD
Methylergometrine—Dizziness—Progesterone—uterine cancer	0.00562	0.00718	CcSEcCtD
Methylergometrine—Vomiting—Progesterone—uterine cancer	0.00541	0.0069	CcSEcCtD
Methylergometrine—Rash—Progesterone—uterine cancer	0.00536	0.00684	CcSEcCtD
Methylergometrine—Dermatitis—Progesterone—uterine cancer	0.00536	0.00684	CcSEcCtD
Methylergometrine—HTR2B—myometrium—uterine cancer	0.00534	0.0722	CbGeAlD
Methylergometrine—Headache—Progesterone—uterine cancer	0.00533	0.0068	CcSEcCtD
Methylergometrine—Thrombophlebitis—Doxorubicin—uterine cancer	0.0053	0.00677	CcSEcCtD
Methylergometrine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00527	0.00673	CcSEcCtD
Methylergometrine—Muscle spasms—Etoposide—uterine cancer	0.00513	0.00654	CcSEcCtD
Methylergometrine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0051	0.0065	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Epirubicin—uterine cancer	0.00506	0.00646	CcSEcCtD
Methylergometrine—Nausea—Progesterone—uterine cancer	0.00505	0.00645	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00492	0.00627	CcSEcCtD
Methylergometrine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0049	0.00625	CcSEcCtD
Methylergometrine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00486	0.0062	CcSEcCtD
Methylergometrine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00486	0.0062	CcSEcCtD
Methylergometrine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00483	0.00616	CcSEcCtD
Methylergometrine—Abdominal pain—Dactinomycin—uterine cancer	0.00475	0.00606	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00469	0.00598	CcSEcCtD
Methylergometrine—Convulsion—Etoposide—uterine cancer	0.00462	0.00589	CcSEcCtD
Methylergometrine—Hypertension—Etoposide—uterine cancer	0.0046	0.00587	CcSEcCtD
Methylergometrine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00458	0.00584	CcSEcCtD
Methylergometrine—Chest pain—Etoposide—uterine cancer	0.00454	0.00579	CcSEcCtD
Methylergometrine—Anaphylactic shock—Etoposide—uterine cancer	0.00435	0.00555	CcSEcCtD
Methylergometrine—Tachycardia—Etoposide—uterine cancer	0.00425	0.00542	CcSEcCtD
Methylergometrine—Hyperhidrosis—Etoposide—uterine cancer	0.00421	0.00537	CcSEcCtD
Methylergometrine—Angina pectoris—Epirubicin—uterine cancer	0.00418	0.00533	CcSEcCtD
Methylergometrine—HTR2B—uterine cervix—uterine cancer	0.00416	0.0562	CbGeAlD
Methylergometrine—Diarrhoea—Dactinomycin—uterine cancer	0.00411	0.00525	CcSEcCtD
Methylergometrine—Hypotension—Etoposide—uterine cancer	0.00407	0.00519	CcSEcCtD
Methylergometrine—HTR2B—smooth muscle tissue—uterine cancer	0.00404	0.0546	CbGeAlD
Methylergometrine—HTR2B—decidua—uterine cancer	0.00396	0.0535	CbGeAlD
Methylergometrine—Paraesthesia—Etoposide—uterine cancer	0.00391	0.00499	CcSEcCtD
Methylergometrine—Dyspnoea—Etoposide—uterine cancer	0.00388	0.00495	CcSEcCtD
Methylergometrine—Angina pectoris—Doxorubicin—uterine cancer	0.00387	0.00493	CcSEcCtD
Methylergometrine—Vomiting—Dactinomycin—uterine cancer	0.00382	0.00488	CcSEcCtD
Methylergometrine—Rash—Dactinomycin—uterine cancer	0.00379	0.00484	CcSEcCtD
Methylergometrine—HTR2B—endometrium—uterine cancer	0.00376	0.0508	CbGeAlD
Methylergometrine—Haematuria—Epirubicin—uterine cancer	0.00365	0.00465	CcSEcCtD
Methylergometrine—Nausea—Dactinomycin—uterine cancer	0.00357	0.00456	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Etoposide—uterine cancer	0.00356	0.00454	CcSEcCtD
Methylergometrine—Bradycardia—Epirubicin—uterine cancer	0.00349	0.00446	CcSEcCtD
Methylergometrine—HTR2B—uterus—uterine cancer	0.00346	0.0468	CbGeAlD
Methylergometrine—Abdominal pain—Etoposide—uterine cancer	0.00344	0.00439	CcSEcCtD
Methylergometrine—Haematuria—Doxorubicin—uterine cancer	0.00337	0.00431	CcSEcCtD
Methylergometrine—HTR2C—female reproductive system—uterine cancer	0.00331	0.0448	CbGeAlD
Methylergometrine—Bradycardia—Doxorubicin—uterine cancer	0.00323	0.00413	CcSEcCtD
Methylergometrine—Tinnitus—Epirubicin—uterine cancer	0.0032	0.00408	CcSEcCtD
Methylergometrine—Cardiac disorder—Epirubicin—uterine cancer	0.00319	0.00407	CcSEcCtD
Methylergometrine—HTR2B—female reproductive system—uterine cancer	0.00311	0.0421	CbGeAlD
Methylergometrine—Diarrhoea—Etoposide—uterine cancer	0.00298	0.0038	CcSEcCtD
Methylergometrine—Tinnitus—Doxorubicin—uterine cancer	0.00296	0.00378	CcSEcCtD
Methylergometrine—Cardiac disorder—Doxorubicin—uterine cancer	0.00295	0.00376	CcSEcCtD
Methylergometrine—Dizziness—Etoposide—uterine cancer	0.00288	0.00367	CcSEcCtD
Methylergometrine—Muscle spasms—Epirubicin—uterine cancer	0.00287	0.00367	CcSEcCtD
Methylergometrine—HTR2B—vagina—uterine cancer	0.00282	0.0381	CbGeAlD
Methylergometrine—Vomiting—Etoposide—uterine cancer	0.00277	0.00353	CcSEcCtD
Methylergometrine—Rash—Etoposide—uterine cancer	0.00274	0.0035	CcSEcCtD
Methylergometrine—Dermatitis—Etoposide—uterine cancer	0.00274	0.0035	CcSEcCtD
Methylergometrine—Headache—Etoposide—uterine cancer	0.00273	0.00348	CcSEcCtD
Methylergometrine—Muscle spasms—Doxorubicin—uterine cancer	0.00266	0.00339	CcSEcCtD
Methylergometrine—Palpitations—Epirubicin—uterine cancer	0.00264	0.00337	CcSEcCtD
Methylergometrine—Convulsion—Epirubicin—uterine cancer	0.00259	0.0033	CcSEcCtD
Methylergometrine—Nausea—Etoposide—uterine cancer	0.00258	0.0033	CcSEcCtD
Methylergometrine—Hypertension—Epirubicin—uterine cancer	0.00258	0.00329	CcSEcCtD
Methylergometrine—Chest pain—Epirubicin—uterine cancer	0.00254	0.00325	CcSEcCtD
Methylergometrine—Palpitations—Doxorubicin—uterine cancer	0.00244	0.00312	CcSEcCtD
Methylergometrine—Anaphylactic shock—Epirubicin—uterine cancer	0.00244	0.00311	CcSEcCtD
Methylergometrine—Convulsion—Doxorubicin—uterine cancer	0.0024	0.00306	CcSEcCtD
Methylergometrine—Nervous system disorder—Epirubicin—uterine cancer	0.00239	0.00305	CcSEcCtD
Methylergometrine—Hypertension—Doxorubicin—uterine cancer	0.00239	0.00305	CcSEcCtD
Methylergometrine—Tachycardia—Epirubicin—uterine cancer	0.00238	0.00304	CcSEcCtD
Methylergometrine—Hyperhidrosis—Epirubicin—uterine cancer	0.00236	0.00301	CcSEcCtD
Methylergometrine—Chest pain—Doxorubicin—uterine cancer	0.00235	0.003	CcSEcCtD
Methylergometrine—Hypotension—Epirubicin—uterine cancer	0.00228	0.00291	CcSEcCtD
Methylergometrine—Anaphylactic shock—Doxorubicin—uterine cancer	0.00226	0.00288	CcSEcCtD
Methylergometrine—HTR2A—epithelium—uterine cancer	0.00224	0.0303	CbGeAlD
Methylergometrine—Nervous system disorder—Doxorubicin—uterine cancer	0.00221	0.00282	CcSEcCtD
Methylergometrine—Tachycardia—Doxorubicin—uterine cancer	0.0022	0.00281	CcSEcCtD
Methylergometrine—Paraesthesia—Epirubicin—uterine cancer	0.00219	0.00279	CcSEcCtD
Methylergometrine—Hyperhidrosis—Doxorubicin—uterine cancer	0.00218	0.00278	CcSEcCtD
Methylergometrine—Dyspnoea—Epirubicin—uterine cancer	0.00217	0.00277	CcSEcCtD
Methylergometrine—HTR2A—smooth muscle tissue—uterine cancer	0.00216	0.0291	CbGeAlD
Methylergometrine—Hypotension—Doxorubicin—uterine cancer	0.00211	0.00269	CcSEcCtD
Methylergometrine—HTR2A—renal system—uterine cancer	0.00208	0.0281	CbGeAlD
Methylergometrine—Paraesthesia—Doxorubicin—uterine cancer	0.00203	0.00259	CcSEcCtD
Methylergometrine—Dyspnoea—Doxorubicin—uterine cancer	0.00201	0.00257	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Epirubicin—uterine cancer	0.00199	0.00254	CcSEcCtD
Methylergometrine—Abdominal pain—Epirubicin—uterine cancer	0.00193	0.00246	CcSEcCtD
Methylergometrine—CYP3A4—renal system—uterine cancer	0.00192	0.026	CbGeAlD
Methylergometrine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00185	0.00235	CcSEcCtD
Methylergometrine—HTR2B—lymph node—uterine cancer	0.00182	0.0246	CbGeAlD
Methylergometrine—Abdominal pain—Doxorubicin—uterine cancer	0.00178	0.00228	CcSEcCtD
Methylergometrine—Diarrhoea—Epirubicin—uterine cancer	0.00167	0.00213	CcSEcCtD
Methylergometrine—HTR2A—female reproductive system—uterine cancer	0.00166	0.0225	CbGeAlD
Methylergometrine—Dizziness—Epirubicin—uterine cancer	0.00161	0.00206	CcSEcCtD
Methylergometrine—Vomiting—Epirubicin—uterine cancer	0.00155	0.00198	CcSEcCtD
Methylergometrine—Diarrhoea—Doxorubicin—uterine cancer	0.00154	0.00197	CcSEcCtD
Methylergometrine—CYP3A4—female reproductive system—uterine cancer	0.00154	0.0208	CbGeAlD
Methylergometrine—Rash—Epirubicin—uterine cancer	0.00154	0.00196	CcSEcCtD
Methylergometrine—Dermatitis—Epirubicin—uterine cancer	0.00154	0.00196	CcSEcCtD
Methylergometrine—Headache—Epirubicin—uterine cancer	0.00153	0.00195	CcSEcCtD
Methylergometrine—HTR2A—vagina—uterine cancer	0.0015	0.0203	CbGeAlD
Methylergometrine—Dizziness—Doxorubicin—uterine cancer	0.00149	0.0019	CcSEcCtD
Methylergometrine—Nausea—Epirubicin—uterine cancer	0.00145	0.00185	CcSEcCtD
Methylergometrine—Vomiting—Doxorubicin—uterine cancer	0.00143	0.00183	CcSEcCtD
Methylergometrine—Rash—Doxorubicin—uterine cancer	0.00142	0.00182	CcSEcCtD
Methylergometrine—Dermatitis—Doxorubicin—uterine cancer	0.00142	0.00181	CcSEcCtD
Methylergometrine—Headache—Doxorubicin—uterine cancer	0.00141	0.0018	CcSEcCtD
Methylergometrine—Nausea—Doxorubicin—uterine cancer	0.00134	0.00171	CcSEcCtD
